CeNeS Pre-clinical Candidate rhGGF2 Cited as Potential Treatment for Schizophrenia
14 mai 2002 02h37 HE
|
CeNeS Pharmaceuticals Plc
CAMBRIDGE, U.K., May 14, 2002 (PRIMEZONE) -- CeNeS Pharmaceuticals plc (LSE:CEN) today noted recent press coverage on the identification of a risk gene for schizophrenia that has implications for its...
CeNeS Announces the Termination of Bioglan Drug Delivery Agreements
02 avr. 2002 04h24 HE
|
CeNeS Pharmaceuticals Plc
CAMBRIDGE, U.K., April 2, 2002 (PRIMEZONE) -- CeNeS Pharmaceuticals plc (LSE:CEN) announced today that it had agreed with the administrators of Bioglan Pharma plc (LSE:BGP), the termination of their...
CeNeS Announces Preliminary Results for the Year- Ended December 31, 2001 (with link)
27 mars 2002 03h16 HE
|
CeNeS Pharmaceuticals Plc
CAMBRIDGE, U.K., March 27, 2002 (PRIMEZONE) -- CeNeS Pharmaceuticals plc (LSE:CEN) today announced its results for the year ended Dec. 31, 2001 and an update on its restructuring plan.
Key events...
CeNeS Signs Agreement to Assign its Head Office Lease
11 déc. 2001 05h01 HE
|
CeNeS Pharmaceuticals Plc
CAMBRIDGE, U.K., Dec. 11, 2001 (PRIMEZONE) -- CeNeS Pharmaceuticals plc (LSE:CEN) announced today that it had exchanged contracts to assign its head office lease at Compass House, Cambridge to De...
CeNeS Announces the Sale of its Chemical Library of Ion Channel Blockers to Scion Pharmaceuticals Inc. for up to $2.8 Million (with link)
29 nov. 2001 02h22 HE
|
CeNeS Pharmaceuticals Plc
CAMBRIDGE, U.K., Nov. 29, 2001 (PRIMEZONE) -- CeNeS Pharmaceuticals plc (LSE:CEN) announced today that it has signed an agreement to sell its chemical library of ion channel blockers to Scion...
CeNeS Signs AutoPatch Technology Agreement with Wyeth-Ayerst Research, a Division of American Home Products Corporation
14 nov. 2001 02h43 HE
|
CeNeS Pharmaceuticals Plc
CAMBRIDGE, United Kingdom, Nov. 14, 2001 (PRIMEZONE) -- CeNeS Pharmaceuticals plc (LSE:CEN) announced today that it had signed an agreement worth $1.2 million for the supply of its proprietary ion...
CeNeS Announces Restructuring Program Update (with link)
12 nov. 2001 03h53 HE
|
CeNeS Pharmaceuticals Plc
CAMBRIDGE, UK, Nov. 12, 2001 (PRIMEZONE) -- CeNeS Pharmaceuticals plc (LSE:CEN) today announced an update on the progress it has made in the group restructuring that was first announced on October 1,...
CeNeS Announces Termination of the Opiate Spray Agreements with Bioglan (with link)
30 oct. 2001 12h37 HE
|
CeNeS Pharmaceuticals Plc
CAMBRIDGE, UK, Oct. 30, 2001 (PRIMEZONE) -- CeNeS Pharmaceuticals plc (LSE:CEN) today announced that it is terminating the development and licence agreements it has with Bioglan Pharma Plc (LSE:BGP)...
CeNeS Reports 2001 Interim Results and Planned Restructuring
01 oct. 2001 03h18 HE
|
CeNeS Pharmaceuticals Plc
CAMBRIDGE, UK, Oct. 1, 2001 (PRIMEZONE) -- CeNeS Pharmaceuticals plc (LSE:CEN) today announced its unaudited interim financial results for the six months ended June 30, 2001 and a planned...
CeNeS Announces Strategic Alliance with Cardinal Health Subsidiary, IPC (International Processing Corp.) (with link)
17 sept. 2001 02h29 HE
|
CeNeS Pharmaceuticals Plc
CAMBRIDGE, UK, Sept. 16, 2001 (PRIMEZONE) -- CeNeS Pharmaceuticals Plc (LSE:CEN) today announced that it's drug delivery division, based in Scotland, has signed a strategic alliance with...